Athira’s Fosgonimeton Fails In Phase II/III LIFT-AD Trial, Future Uncertain

Phase I Next-Gen Drug May Become Priority

 
• By Mandy Jackson
  
Mist at the potential end of a road
It's unclear whether the LIFT-AD failure is the end of the road for Athira's drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D